Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Ayanite Microorganism

Explore full profile
ChinaFounded 2016Biotech & Life Sciences
Valuation $1–2.5B Last recorded · 2022
Total funding $100–500M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Ayanite Microorganism and the history behind them.

At a glance

Status
Operational
Founded
2016
Headquarters
China
Open positions
None listed
Dealroom signal
17.8/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotech & Life Sciences, Biotechnology, Rumoured $1B, Biotech and Pharma, DT and LS, science-based
Business model
Manufacturing
Client focus
b2b

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

1 recorded event

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES BOther financing Jan 2022 $206M $825M Undisclosed ↗
Showing the latest 1 of 1 recorded eventsBook a demo for the full funding history →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

CompanyHeadquartersStatusEmployeesTotal fundingValuation
AirNexis TherapeuticsPulmonary disease therapeutics for chronic obstructive pulmonary disease Palo Alto, United States Operational — $200M $800M
Alveus TherapeuticsNext-generation obesity and metabolic disease therapies Philadelphia, United States Operational
Braveheart BioLate-stage therapeutics for hypertrophic cardiomyopathy San Francisco, United States Operational
Crystalys TherapeuticsClinical-stage biopharmaceutical developing therapies for gout San Diego, United States Operational
Antares TherapeuticsDevelopment of precision oncology therapies, utilizing acquired discovery capabilities and a validated pipeline for patient treatments Boston, United States Operational
Callio TherapeuticsBiotechnology firm advancing multi-payload ADCs for targeted cancer therapy with innovative HER2 solutions Seattle, United States Operational
Tenvie TherapeuticsPrecision-designed small molecule therapies enhancing CNS penetration for diverse neurological diseases San Francisco, United States Operational
Seaport TherapeuticsDeveloping new neuropsychiatric medicines, specifically antidepressants and anxiolytics Boston, United States Operational
Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

0 profiles shownExplore the complete relationship graph →

Talent

Book a demo to see the people
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇨🇳 China HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Ayanite Microorganism on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Ayanite Microorganism’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Request a free trial

Takes under a minute. Already use Dealroom? Log in.